Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down's syndrome.
We examined amyloid precursor protein (APP) mRNAs expression in skin fibroblasts from Down's syndrome (DS) patients of different ages to determine the time of occurrence of abnormal splicing. The ratio of APP770 + 751 mRNA to APP695 mRNA (APP770 + 751/695) was significantly increased in the young DS group and adult DS group compared with the age-matched control groups (p < 0.01, p < 0.05), but no significant increase was observed in the aged DS group compared with the age-matched control group. These findings suggest that metabolic abnormalities of the APP gene occur at a very early stage of DS, at a mean age of about 5 years. Therefore, metabolic abnormalities of the APP gene are considered to appear at a very young age also Alzheimer's disease (AD). In this study, we confirmed that examination of the APP gene in skin fibroblasts might be useful for early diagnosis of AD.
Urakami
K
K
Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan.
Kataoka
J
J
Okada
A
A
Isoe
K
K
Wakutani
Y
Y
Ji
Y
Y
Adachi
Y
Y
Ohno
K
K
Takahashi
K
K
D000328:Adult; D000367:Age Factors; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D001345:Autoradiography; D002648:Child; D004314:Down Syndrome / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D012333:RNA, Messenger / Q000378:metabolism*; D012867:Skin / Q000378:metabolism*
D016564:Amyloid beta-Protein Precursor; D012333:RNA, Messenger